Navigation Links
Tethys Bioscience Announces Acquisition of Lipomics Technologies
Date:9/17/2008

of Tethys. Steven M. Watkins, PhD., co-founder, president and chief scientific officer of Lipomics, will assume the role of chief technology officer at Tethys. The Lipomics facility will continue its comprehensive and quantitative profiling of lipid metabolites as Tethys West Sacramento.

"From the moment we began discussions with Tethys, we were each struck by the complementary nature of our technologies, our core skills, and our sharp focus on addressing unmet clinical needs," Watkins said. "The Lipomics team is delighted to become part of Tethys, and to bring our expertise to bear on advancing the field of predictive personalized medicine."

About Tethys Bioscience

Tethys Bioscience is a predictive personalized medicine company developing novel tests which address the growing global healthcare challenge of chronic diseases such as diabetes. Founded in 2005, the company integrates an experienced management team, innovative research based on sound science, a CLIA-licensed clinical laboratory, and a commercialization team with extensive experience in diagnostic innovation. Our partnerships with world class researchers and our solid financial foundation will enable Tethys to help transform the management of chronic diseases by providing personalized, preventive solutions that aid every constituency: patients, doctors and the healthcare system as a whole.

About Lipomics

Lipomics Technologies provides industry-leading metabolic assessments for drug research, clinical diagnostics and personalized medicine. The Company's proprietary analytical technologies generate comprehensive, accurate and quantitative profiles of lipid metabolites. Lipomics delivers deep and rich knowledge about biological and metabolic changes induced by disease, drug action, nutritional or lifestyle influences. In partnership with pharmaceutical, biotechnology, and nutrition companies, Lipomics uses its technologies to discover new diagnostic biomarkers, improve dr
'/>"/>

SOURCE Tethys Bioscience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test
2. Ardea Biosciences to Present at the UBS Global Life Sciences Conference and the Third Annual JMP Securities Healthcare Focus Conference
3. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
4. Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines
5. Ardea Biosciences to Present Data on Gout and Inflammation Programs at the 2008 ACR/ARHP Annual Scientific Meeting
6. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
7. Ardea Biosciences to Present Data on Lead MEK inhibitor, RDEA119, at EORTC-NCI-AACR Symposium
8. Protect Marylands Bioscience Industry
9. Start-Up and Emerging Biotech Companies Will Tell Their Stories at Biosciences Showcase Planned for MichBio Expo
10. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
11. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... New York, NY (PRWEB) January 14, 2014 ... has initiated coverage of Alliqua, Inc. (OTCQB: ALQA). ... manufacturing, and marketing proprietary products to serve the ... http://equitiesiq.com/reports/alliqua/ , In late 2012, Alliqua was ... which launched the company’s new strategy to become ...
(Date:1/14/2014)... 2014 In recent years, growing ... and methods in product development and promotion has ... the industry. This mistrust, fueled by concerns about ... been further fed by reports of spectacular fines ... activities, allegations of industry suppression of negative clinical ...
(Date:1/14/2014)... Cardiff, UK (PRWEB) January 13, 2014 ... leader with more than 20 years in the industry, ... and photonics . Hainsey will serve as the society’s ... have Dr. Hainsey join SPIE as our Technology Strategist, ... said Dr. Andrew Brown, SPIE Senior Director for Global ...
(Date:1/14/2014)... 2014 BioMedomics, Inc. , a ... POC diagnostic platforms and novel disease specific POC tests, ... round of financing netting a total of $690,000. The ... outside equity capital in the company. This group of ... in diagnostics companies and includes Tom Roberg who was ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2BioMedomics, Inc. Closes $690K Round of Financing 2
... the Trudeau Institute may help to explain why live ... protection. The research is published in this month,s ... entitled "Live attenuated influenza vaccine (LAIV) impacts innate and ... scientist Dr. Laura Haynes and her colleagues. "Our ...
... ARBOR, Mich.---A delicate balance of atomic forces can be ... size---an attribute that,s important for many nanotech applications but ... The same type of forces are at work ... inorganic supercluster structures in this research are in many ...
... ST. LOUIS, Aug. 23, 2011 Bunge North America, ... BG ), issued the following statement which can be ... "Bunge North America is aware from press ... prior conversations with Syngenta, we are surprised and disappointed that ...
Cached Biology Technology:Trudeau Institute announces a discovery in how FluMist elicits protection 2Engineers discover nanoscale balancing act that mirrors forces at work in living systems 2Bunge Responds to Syngenta Suit 2
(Date:4/16/2014)... up, and you cannot lift your upper eyelid. You walk ... eyes look straight when they are rolled down in the ... allow people a normal position of their head. In order ... this happens. , In a paper published in the April ... of Iowa researchers Bernd Fritzsch and Jeremy Duncan and their ...
(Date:4/16/2014)... Adam Arkin, director of the Physical Biosciences Division ... a biologist who is recognized as a leading ... networks and populations and their application to systems ... six recipients of the 2013 Ernest Orlando Lawrence ... E.O. Lawrence Award, the Department of Energy (DOE),s ...
(Date:4/16/2014)... Aktories and Dr. Panagiotis Papatheodorou from the Institute of ... of Freiburg have discovered the receptor responsible for smuggling ... into the cell. The TpeL toxin, which is formed ... gas gangrene and food poisoning. It is very similar ... the genus Clostridium . The toxins bind to ...
Breaking Biology News(10 mins):Researchers track down cause of eye mobility disorder 2Berkeley Lab's Adam Arkin wins 2013 Lawrence Award 2Berkeley Lab's Adam Arkin wins 2013 Lawrence Award 3Gate for bacterial toxins found 2
... give the Anne McLaren Memorial Lecture at the UK National Stem ... to screening for drugs that target stem cells. To begin with, ... for new drugs to promote wound healing and aid the use ... can also be applied to a wide range of stem cells, ...
... food source, with a global harvest now at 110 million ... But epidemics of infectious disease threaten this vital industry, including ... Perhaps even more worrisome: these infections can spread to wild ... escaping from them. Heart and skeletal muscle ...
... nanotechnology in the field of drug delivery has attracted ... holds great promise for the development of targeted, localized ... are affected. Such targeted-therapy methods would ... anticancer drugs are distributed throughout the body, attacking healthy ...
Cached Biology News:Top professor will report new way to discover drugs that aid regenerative medicine 2New virus may pose risk to wild salmon 2Researchers use nanoparticles to shrink tumors in mice 2Researchers use nanoparticles to shrink tumors in mice 3